Insulin resistance syndrome

被引:0
作者
Rao, G [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15215 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Insulin resistance can be linked to diabetes, hypertension, dyslipidemia. cardiovascular disease and other abnormalities. These abnormalities constitute the insulin resistance syndrome. Because resistance usually develops long before these diseases appear, identifying and treating insulin-resistant patients has potentially great preventive value. Insulin resistance should be suspected in patients with a history of diabetes in first-degree relatives; patients with a personal history of gestational diabetes, polycystic ovary syndrome or impaired glucose tolerance; and obese patients, particularly those with abdominal obesity. Present treatment consists of sensible lifestyle changes. including weight loss to attain healthy body weight. 30 minutes of accumulated moderate-intensity physical activity per day and increased dietary fiber intake. Pharmacotherapy is not currently recommended for patients with isolated insulin resistance.
引用
收藏
页码:1159 / 1163
页数:5
相关论文
共 26 条
  • [1] Drug therapy - Metformin
    Bailey, CJ
    Turner, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) : 574 - 579
  • [2] EFFECT OF INTRA-ARTERIAL INSULIN ON TISSUE CHOLESTEROL AND FATTY ACIDS IN ALLOXAN-DIABETIC DOGS
    CRUZ, AB
    GRANDE, F
    HAY, LJ
    AMATUZIO, DS
    [J]. CIRCULATION RESEARCH, 1961, 9 (01) : 39 - &
  • [3] INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    DEFRONZO, RA
    FERRANNINI, E
    [J]. DIABETES CARE, 1991, 14 (03) : 173 - 194
  • [4] Relationship between insulin resistance and nonmodulating hypertension - Linkage of metabolic abnormalities and cardiovascular risk
    Ferri, C
    Bellini, C
    Desideri, G
    Valenti, M
    De Mattia, G
    Santucci, A
    Hollenberg, NK
    Williams, GH
    [J]. DIABETES, 1999, 48 (08) : 1623 - 1630
  • [5] FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
  • [6] Insulin resistance in the pathogenesis of dyslipidemia
    Garg, A
    [J]. DIABETES CARE, 1996, 19 (04) : 387 - 389
  • [7] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [8] Insulin resistance syndrome: Options for treatment
    Granberry, MC
    Fonseca, VA
    [J]. SOUTHERN MEDICAL JOURNAL, 1999, 92 (01) : 2 - 14
  • [9] HOLLOSZY JO, 1986, ACTA MED SCAND, P55
  • [10] Kahn R, 1998, DIABETES CARE, V21, P310